Advanced Oncotherapy (AVO) – Appointment of Joint Broker

Advanced Oncotherapy (AVO), the developer of next-generation proton therapy systems for cancer treatment, announces the appointment of Stifel Nicolaus Europe Limited as Joint Broker to the Company, with immediate effect. Stockdale Securities remains Nominated Adviser to the Company. Advanced Oncotherapy Plc www.avoplc.com Dr Michael Sinclair, Executive Chairman Nicolas Serandour, CEO Tel: +44 20 3617 8728    Stockdale Securities (Nomad & […]